Instem Presenting at Society of Toxicologic Pathology Annual Meeting
Instem Presenting on Extraction and Normalization of Toxicologic Pathology Terminology
CONSHOHOCKEN, PA - June 19th, 2012 - - Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that Instem Life Scientist, Stephanie Berry will be representing Instem’s poster presentation at the 31st Annual Society of Toxicologic Pathology Meeting and Symposium in Boston, MA.
The presentation will outline how Instem's Metawise™ technology was used to harmonize the varied language used within key guideline sources of pathology nomenclature. Poster co-author and Head of Semantic and Visual Applications with Instem, Paul Bradley commented, “The results of this work could form the basis of a microhistopathology controlled terminology for use in current studies. It also provides a means for retrospective translation and alignment of pathology findings from historic studies, which is particularly relevant in the current climate of pharmaceutical companies looking to maximise data reuse and accessibility."
The Society of Toxicologic Pathology (STP) is a nonprofit association of pathologists and other scientists who focus on advancing pathology as it applies to changes in pharmacological, chemical, or environmental agents.
“Metawise: Extraction and Normalization of Toxicologic Pathology Terminology from the INHAND Project for Enhanced Search” will be on display at the STP Exhibit Hall from Sunday evening, June 24th through Wednesday afternoon, June 27th, 2012.
This year’s annual meeting is expected to attract over 600 attendees and 33 exhibitors from around the world to the Boston Marriott Copley Place. Instem will be exhibiting at booth #206 during the Exhibit Hall which will be open from Monday, June 25th through Wednesday, June 27th.
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600